Stay updated on Prevent Early Onset AD Clinical Trial
Sign up to get notified when there's something new on the Prevent Early Onset AD Clinical Trial page.

Latest updates to the Prevent Early Onset AD Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2, reflecting an administrative update. This change does not affect study information or functionality.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded the full citation for Bateman et al., 2012 NEJM. Removed the Erratum reference.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision metadata updated: added Revision v3.5.0 and removed Revision v3.4.3.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing the previous v3.4.2. This update is a minor front-end change and does not modify the study details or functionality.SummaryDifference0.0%

- Check62 days agoChange DetectedThe publication 'Clinical and biomarker changes in dominantly inherited Alzheimer's disease' (NEJM 2012) was added and subsequently removed, resulting in no net change to the Publications section.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded new study sites: Dublin, Ireland (DUBLIN 4); Barcelona, Spain; and San Juan, Puerto Rico, and included Alzheimer’s Research Australia. Removed previously listed locations including Dublin (DUBLIN 4), Barcelona (Spain) and San Juan (Puerto Rico), and the Mental Health Research Institute.SummaryDifference0.5%

Stay in the know with updates to Prevent Early Onset AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prevent Early Onset AD Clinical Trial page.